ACA/USDT — Trade Plan (Acala)


$ACA #MicronMarketCapBreaks1Trillion
ℹ️ Spot token — no leverage decay. ACA is the native token of Acala, a DeFi hub on Polkadot. This is a real asset trade, unlike the previous leveraged short tokens.
Market Read
ACA has broken out of a prolonged base, up 45% today and 55% over 30 days — the first signs of sustained recovery after catastrophic 180-day (-92%) and 1-year (-96.69%) losses. The chart shows a clean impulsive move from the 0.00067 base, with price reaching a 24h high of 0.0010943 before pulling back to 0.0009982, just below the Bollinger UB (0.0010273). SuperTrend at 0.0007784 is rising and acting as a solid trailing floor. MACD is bullish with DIF (0.0000637) comfortably above DEA (0.0000478) — momentum is intact, not exhausted. The 7-day and 30-day positive returns suggest this is a developing trend, not a one-day pump.
The main concern is very thin liquidity — only 328K USDT daily turnover. Moves can be sharp in both directions.
Trade Scenarios
Scenario A — Pullback Entry (Best Setup)
Price retesting the MB or SuperTrend zone offers the cleanest risk/reward.
Entry zone: 0.0008200–0.0008400 (MB confluence)
Target 1: 0.0010943 (24h high)
Target 2: 0.0011420–0.0012000 (chart extension)
Stop-loss: 0.0007600 (below SuperTrend)
R/R: approximately 1:3
Scenario B — Current Level Entry
Entering near the UB at 0.0009982 is riskier but valid if the pullback holds and a new green candle forms with volume.
Entry: 0.0009900–0.0010000
Target: 0.0010943–0.0011500
Stop-loss: 0.0009200 (mid-range support)
R/R: approximately 1:1.5
Breakout scenario: A clean hourly close above 0.0010943 on volume would confirm continuation toward 0.0012–0.0013.
Risk Considerations
Despite being a spot token, ACA's long-term chart is one of the most damaged in crypto (-96.69% annual). This recovery may be sustainable or may fade — the 30-day trend is encouraging but thin liquidity means a few large sells can erase gains fast. Position size: 1–2% max. Scale in rather than going all-in at one level.
ACA42%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned